Evolent Health, Inc.
EVH
$4.72
-$0.02-0.42%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -287.10% | -355.69% | -767.39% | -77.46% | -75.30% |
| Total Depreciation and Amortization | 47.89% | 37.92% | 30.18% | -41.03% | -36.86% |
| Total Amortization of Deferred Charges | 20.30% | 13.25% | 11.35% | 1.01% | -10.06% |
| Total Other Non-Cash Items | 220.06% | 246.83% | 444.80% | 56.51% | 40.53% |
| Change in Net Operating Assets | 91.21% | 54.70% | 50.77% | -1,094.72% | -780.02% |
| Cash from Operations | 262.96% | 80.74% | 107.00% | -126.93% | -118.91% |
| Capital Expenditure | 129.58% | 30.59% | -2.93% | -91.18% | -182.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -194.58% | -194.58% | -194.58% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 106.16% | 99.81% | 99.86% | 58.77% | -17.72% |
| Cash from Investing | 153.22% | 109.74% | 99.63% | -108.58% | -219.38% |
| Total Debt Issued | -33.10% | -33.10% | 596.61% | 14.53% | -28.58% |
| Total Debt Repaid | -368.74% | -352.61% | -- | 45.18% | 85.49% |
| Issuance of Common Stock | -- | -- | -- | -- | -73.92% |
| Repurchase of Common Stock | -654.47% | -612.28% | -188.04% | -178.40% | 67.39% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 89.92% | 66.55% | 44.60% | 22.05% | 6.20% |
| Other Financing Activities | 75.65% | 94.79% | -66.45% | 96.73% | 94.29% |
| Cash from Financing | -180.18% | -259.89% | -6,258.23% | 184.71% | 188.89% |
| Foreign Exchange rate Adjustments | -467.84% | -553.57% | -112.23% | -257.66% | -19.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -191.21% | -345.91% | 104.89% | 115.68% | 157.46% |